Schering names VPs
Executive Summary
Schering-Plough names James McLeod global VP-clinical development, early clinical research & experimental medicine. McLeod is a former Novartis VP; he will report to group VP Enrico Veltri. The company also appoints Christopher Kelly as VP-global information technology, global supply chain/global quality operations. Kelly will report to Chief Information Officer Karl Salnoske...
You may also be interested in...
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.
Roche Gets Adjuvant ALK+ Lung Cancer To Itself With Alecensa Approval
The US FDA cleared Roche’s supplemental approval request for ALK inhibitor Alecensa in ALK-positive non-small cell lung cancer following tumor resection.